Allergan to Present New Data on Investigational Medicines at AAO

Source: Allergan

Allergan will present new data at the annual meeting of the American College of Ophthalmology (AAO) to be held in Chicago. The Retina Subspecialty Day (October 26-27) will feature two late-breaker presentations on the company’s ophthalmology pipeline, including new findings for abicipar in patients with neovascular age-related macular degeneration (AMD) and brimonidine drug delivery system (DDS) in patients with geographic atrophy secondary to AMD. Additional company-sponsored data will also be presented during the AAO poster sessions.

“The data demonstrate our continued dedication to research and innovation aimed at finding new solutions to a cross-section of eye diseases,” David Nicholson, Chief Research & Development Officer at Allergan, said in a company news release. “At AAO, we look forward to presenting results from studies that have the potential to define new treatment approaches as well as continue to improve upon current patient care.”

Allergan will present five abstracts, including two podium and three poster presentations (all noted in local Central Daylight Time):

Retina Subspecialty Day – Section XI: First-time Results of Clinical Trials (Friday, October 26, 5:08-5:36 PM):

  • Safety and Efficacy of Abicipar in Patients with Neovascular Age‐related Macular Degeneration

    o Author:KhuranaR. o Time:5:15-5:22PM

  • Brimonidine DDS Safety and Efficacy in Patients with Geographic Atrophy Secondary to Age-related Macular Degeneration

    o Author:FreemanWetal o Time:5:29-5:36PM

    AAO Poster Session One (Saturday, October 27 – Sunday, October 28) * Authors present Sunday, Oct. 28th, 12:45-1:45 PM):

  • Symptom Relief in Dry Eye Subjects Following Intranasal Tear Neurostimulation o Authors:JerkinsGetal.

  • Real World Neovascular Age-related Macular Degeneration Treatment and Outcomes: Analyses of US Electronic Health Records

    o Authors:KissSetal.

  • Real-World Efficacy of Selective Laser Trabeculoplasty in the UK and Factors Predicting Success

    *Additional presentation in the Poster Theater, Sunday, Oct. 28th, 3:30-4:30 PM

 Authors: Khawaja A et al.


Allergan will host an Analyst Event at the 2018 AAO Annual Meeting including a conference call and webcast on Friday, October 26, at 6:30 p.m. Central Time (7:30 p.m. Eastern Time). The dial-in number to access the call is U.S./Canada (877) 251-7980, International (706) 643-1573, and the conference ID is 1974409.

A replay of the conference call will also be available beginning approximately two hours after the call’s conclusion and will remain available through 10:30 p.m. Eastern Time on November 26, 2018. The replay may be accessed by dialing (855) 859-2056 or (404) 537-3406 and entering the conference ID 1974409.

To access the webcast, please visit Allergan’s Investor Relations website at https://www.allergan.com/investors/events-presentations. A replay of the webcast will also be available on Allergan’s Investor Relations website.

Related Content